sulfan blue has been researched along with Breast Cancer in 98 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (6.12) | 18.2507 |
2000's | 52 (53.06) | 29.6817 |
2010's | 38 (38.78) | 24.3611 |
2020's | 2 (2.04) | 2.80 |
Authors | Studies |
---|---|
Aubin, F; Castelain, F; Girardin, P; Jeand'heur, A; Moumane, L; Pelletier, F | 1 |
Frountzas, M; Karathanasis, P; Michalopoulos, NV; Schizas, D; Theodoropoulos, C; Vrakopoulou, GZ; Zografos, CG; Zografos, GC | 1 |
Alves, KL; Freitas-Junior, R; Moreira, MA; Oliveira, LF; Paulinelli, RR; Peleja, MB; Rahal, RM; Resende, TC; Vilela, MH | 1 |
Alves, M; Azevedo, JP; Ribeiro, C; Todo Bom, A | 1 |
Green, M; Gregg, L; Ives, C; Trust, C | 1 |
López-Gómez, V; Moreno-Martínez, A; Varela-Durán, M | 1 |
Alves, VC; Crisanto, ML; Ibiapina, JO; Oliveira, TC; Soares, EC; Vieira, SC | 1 |
Ang, CH; Chan, MY; Chen, JC; Seah, DW; Tan, EY; Tan, MY; Teo, C | 1 |
Barneveld, PC; Bavelaar-Croon, CD; Bosscha, K; Contant, CM; de Roos, WK; van la Parra, RF | 1 |
Gao, W; Guo, W; Ji, J; Liu, J; Tong, M; Zhang, L | 1 |
Inaji, H; Inoue, T; Nakano, Y; Nishi, T; Nishimae, A; Sawai, Y; Yamasaki, M | 1 |
Asano, N; Ikemoto, K; Ishiyama, T; Kotoda, M; Matsukawa, T; Mitsui, K; Sato, H; Sessler, DI | 1 |
Berglund, D; Lindvall, P; Lubenow, N | 1 |
Ahmed, M; Anninga, B; Douek, M; Goyal, S; Pankhurst, QA; Young, P | 1 |
Elder, EE; French, J; Kilby, CJ; Ngui, NK; Pathmanathan, N | 1 |
Bergkvist, L; Christiansen, PM; Daskalakis, K; Eriksson, S; Fischer, L; Hedin, C; Jørnsgård, H; Karakatsanis, A; Markopoulos, CJ; Pistioli, L; Rasmussen, NR; Sund, M; Tegnelius, D; Wärnberg, F | 1 |
Aurich, S; Seitz, AT; Simon, JC; Tomm, J; Treudler, R | 1 |
Bakala, J; Duben, J; Dudesek, B; Gatek, J; Hnátek, L; Hradská, K; Kotoc, J; Musil, T; Vázan, P | 1 |
Bühler H, S; Cayazzo M, D; Cunill C, E; Hamilton S, J; Rojas P, H; Vesperinas A, G | 1 |
Dixon, JM; Kehoe, T; Mak, C; Millar, AM; Radhakrishna, S; Thomas, JS; Wong, D | 1 |
Hanby, A; Hardie, LJ; Horgan, K; Masannat, YA | 1 |
Chan, JK; Cheuk, W; Poon, M; Wu, LL | 1 |
Bomanji, J; Chicken, DW; Ell, PJ; Keshtgar, MR; Somasundaram, SK; Waddington, WA | 1 |
Ewan, PW; Haque, RA; Nasser, SM; Wagner, A; Whisken, JA | 1 |
Barthelmes, L; Goyal, A; Mansel, RE; McNeill, F; Newcombe, RG | 1 |
Fondrinier, E; Interne, SB; Laine, P; Lucas, N; Nicolie, B | 1 |
Akashi, S; Hojo, T; Kikuyama, M; Kinoshita, T; Nagao, T | 1 |
Reutershan, J; Rogler, V; Röhm, C | 1 |
Barthelmes, L; Goyal, A; Mansel, RE; Sudheer, P | 1 |
Chishima, T; Endo, I; Ichikawa, Y; Inayama, Y; Ishikawa, T; Kito, A; Momiyama, N; Narui, K; Nozawa, A; Sasaki, T; Shimada, H; Shimizu, D | 1 |
Asselbergs, CP; Blokker, RS | 1 |
Chan, M; Chow, MP; Chu, T; Hung, WK; Lui, CY; Mak, KL; Ying, M | 1 |
Forrer, F; Güth, U; Myrick, ME; Obermann, EC; Rochlitz, C; Schmid, SM; Viehl, CT | 1 |
Avisar, E; Schuman, S; Walker, G | 1 |
Varhaug, JE | 1 |
Bjerkeset, O; Ilsaas, C; Johnsen, L; Lende, TH; Salthe, J; Søiland, H | 1 |
Pyke, C | 1 |
Kollias, J; Russell, WJ | 1 |
Hozumi, Y; Kurihara, K; Kusakabe, M; Lefor, AT; Sata, N; Shiozawa, M; Yasuda, Y | 1 |
Arora, S; Babu, E; Johnson, S | 1 |
Frangioni, JV; Hutteman, M; Liefers, GJ; Lowik, CW; Mieog, JS; Schaafsma, BE; Vahrmeijer, AL; van de Velde, CJ; van der Vorst, JR; Verbeek, FP | 1 |
Eliška, O; Pavlista, D | 1 |
Fujibayashi, M; Hattori, A; Hirano, A; Inoue, H; Kamimura, M; Kim, N; Kinoshita, J; Miyamoto, R; Ogura, K; Okubo, F; Setoguchi, Y; Shimizu, T | 1 |
Dousias, V; Geahchan, N; Iatrakis, G; Navrozoglou, I; Paschopoulos, M; Pechlivani, F; Stefos, T; Zervoudis, S | 1 |
Ahmed, F; Hart, M; Joshi, M; McPherson, S | 1 |
Ancel, B; Brenet, O; Dupoiron, D; Jayr, C; Lalourcey, L; Louvier, N; Maget, B; Malinovsky, JM; Mavoungou, P; Monnin, D; Queinnec, M; Rosay, H | 1 |
Benoit, L; Fraisse, J; Hoyek, T | 1 |
Lee, BB | 1 |
Cserni, G | 1 |
Bonadonna, P; Crivellaro, M; Dama, A; Passalacqua, G; Senna, G | 1 |
Cho, S; Kajita, I; Kayo, R; Murakami, T; Saito, H | 1 |
Bennett, IC; Wetzig, NR; Wilkinson, DS | 1 |
Harman, CR; Martin, RC; Meyer-Rochow, GY | 1 |
Basta, A; Basta, P; Opławski, M; Pityński, K; Tomaszewska, R | 1 |
Kraft, O | 1 |
Meijer, WS; van Wessem, KJ | 1 |
Barber, RW; Bobrow, L; Britton, P; Pain, SJ; Patel, A; Peters, AM; Purushotham, AD; Sinnatamby, R; Warren, R | 1 |
Goyal, A; Mansel, RE; Newcombe, RG | 1 |
Govaert, GA; Oostenbroek, RJ; Plaisier, PW | 1 |
Campos, JM; Casas, JI; Delgado, MO; Landeira, JM; Nasif, LA; Piñol, S | 1 |
Ballarin, A; Casara, D; Denetto, V; Franchini, Z; Marchet, A; Mariani, G; Meggiolaro, F; Nitti, D; Polico, C; Rampin, L; Rubello, D; Zavagno, G | 1 |
Chod, J; Halaska, M; Krízová, H; Rob, L; Strnad, P; Zuntová, A | 1 |
Chan, CM; Chong, SF; Hung, WK; Mak, KL; Ying, M; Yip, AW | 1 |
Abel-Decollogne, F; Benhaijoub, A; Dewachter, P; Mertes, PM; Mouton-Faivre, C | 1 |
Beenen, E; de Roy van Zuidewijn, DB | 1 |
Chhabra, A; Goyal, A; Mansel, RE; Newcombe, RG | 1 |
Bircher, AJ; Figueiredo, V; Scherer, K; Studer, W | 1 |
Littlejohn, DR; Low, KS | 1 |
Beller, U; Carmon, M; Golomb, E; Hershko, DD; Olsha, O; Raveh, D; Reinus, C; Schecter, WP | 1 |
Butarelli, M; Houvenaeghel, G; Marchal, F; Olivier, JB; Verhaeghe, JL | 1 |
Chicken, DW; Keshtgar, MR; Mansouri, R | 1 |
Chicken, DW; Ell, PJ; Keshtgar, MR; Mansouri, R | 1 |
Chetty, U; Chin, PK; Jack, W; Soon, PH; Thomas, JS | 1 |
Clough, KB; Lecuru, F; Lesieur, B; Nos, C | 1 |
Cox, CE; Dhakal, HP; Lamichhane, N; Neupane, PR; Pradhan, M; Shrestha, BM; Thakur, BK | 1 |
Bilski, A; Durczynski, A; Jeziorski, A; Nejc, D; Piekarski, J; Pluta, P; Sek, P; Wronski, K | 1 |
Bibeau, F; Chateau, MC; Delfour, C; Eslimani, M; Gourgou, S; Gutowski, M; Pourquier, D; Quenet, F; Rouanet, P; Saint-Aubert, B; Simony-Lafontaine, J; Thezenas, S; Trentini, F | 1 |
Cassina, E; Mininanni, P; Ponzone, R; Sismondi, P | 1 |
Brunisholz, Y; Delaloye, JF; Spertini, F; Steiger, D; Thierrin, L; Zuber, JP | 1 |
Al Mufti, R; Filippakis, G; Hadjiminas, DJ; Lanitis, S; Lee, TH; Sidhu, V | 1 |
Baĭchev, G; Deliĭski, T; Penkova, R; Popovska, S | 1 |
Barlier, C; Bremond, A; Chassagne, C; Ghnassia, JP; Janser, JC; Mignotte, H; Rodier, JF; Routiot, T; Treilleux, I; Velten, M | 1 |
Fried, D; Salmon, RJ | 1 |
Bourgeois, D; Clough, KB; Freneaux, P; Nos, C; Salmon, RJ; Zafrani, B | 1 |
Bass, SS; Berman, C; Cox, CE; Ku, NN; Reintgen, DS | 1 |
Hardelin, D; Margonari, H; Salvat, J | 1 |
Chatterton, B; Coventry, BJ; Farshid, G; Gill, PG; Kollias, J; Malycha, P | 1 |
Bem, C; Brémond, A; Chassagne-Clément, C; Lopez, R; Martin, X; Mignotte, H; Treilleux, I | 1 |
Bando, E; Michigishi, T; Minato, H; Miwa, K; Nakajima, K; Noguchi, M; Nonomura, A; Tonami, N; Tsugawa, K; Yokoyama, K | 1 |
Fliquete Peris, MV; Fuster Diana, C; Giménez Climent, J; Más Arcas, C; Vázquez Albaladejo, C; Vázquez Forner, C | 1 |
de Kanter, AY; Eggermont, AM; Henzen-Logmans, SC; Krenning, EP; Kruyt, RH; Paul, MA; van Eijck, CH; van Geel, AN; Wiggers, T | 1 |
Bobin, JY; Isaac, S; Joualee, A; Khaled, M; Perrin-Fayolle, O; Spirito, C; Zinzindohoue, C | 1 |
Deacock, SJ; Kissin, MW; Mullan, MH; Quiney, NF | 1 |
Clough, KB; Falcou, MC; Fréneaux, P; Guilbert, S; Nos, C; Salmon, RJ | 1 |
Amaral, BB; Biazús, JV; Cavalheiro, JA; Cerski, CT; Fuchs, SC; Menke, CH; Oliveira, OL; Schwartsmann, G; Spiro, BL; Xavier, NL | 1 |
Baitchev, G; Deliisky, T; Gorchev, G; Popovska, S; Raitcheva, TZ | 1 |
de Vries, J | 1 |
Botella-Estrada, R; Carbonell, M; Giménez, J; Guillén, C; Hernández, D; Martínez, MA; Vázquez, C | 1 |
2 review(s) available for sulfan blue and Breast Cancer
Article | Year |
---|---|
[Anaphylactic shock due to patent blue: four case report and review of literature].
Topics: Adult; Anaphylaxis; Breast Neoplasms; Coloring Agents; Female; Humans; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2010 |
Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes.
Topics: Aged; Anaphylaxis; Breast Neoplasms; Female; Humans; Intraoperative Complications; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Tests; Terminology as Topic | 2006 |
14 trial(s) available for sulfan blue and Breast Cancer
Article | Year |
---|---|
A prospective randomized trial comparing patent blue and methylene blue for the detection of the sentinel lymph node in breast cancer patients.
Topics: Breast Neoplasms; Coloring Agents; Female; Humans; Infusions, Intravenous; Methylene Blue; Middle Aged; Neoplasm Staging; Prospective Studies; Rosaniline Dyes; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2017 |
The effects of Patent Blue dye on peripheral and cerebral oxyhaemoglobin saturations.
Topics: Aged; Anesthetics, Inhalation; Anesthetics, Intravenous; Artifacts; Breast Neoplasms; Cerebrovascular Circulation; Coloring Agents; Diagnostic Errors; Female; Humans; Methyl Ethers; Middle Aged; Monitoring, Intraoperative; Oximetry; Oxyhemoglobins; Propofol; Rosaniline Dyes; Sevoflurane | 2015 |
Axillary reverse mapping in patients with breast cancer: Is it oncologically safe?
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Prospective Studies; Rosaniline Dyes | 2016 |
The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies.
Topics: Breast Neoplasms; Coloring Agents; Denmark; Female; Ferric Compounds; Humans; Magnetite Nanoparticles; Middle Aged; Prospective Studies; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Sweden; Technetium Tc 99m Aggregated Albumin | 2016 |
Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Indocyanine Green; Lymph; Lymphography; Middle Aged; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium | 2010 |
Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; Female; Fluorescence; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Indocyanine Green; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Organotechnetium Compounds; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Spectroscopy, Near-Infrared | 2012 |
Sentinel lymph node detection by intranipple injection of patent blue dye in breast cancer: a preliminary report of a feasibility study.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Coloring Agents; Feasibility Studies; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Nipples; Predictive Value of Tests; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2012 |
Sentinel node biopsy in breast cancer: validation study and comparison of blue dye alone with triple modality localization.
Topics: Antimony; Breast Neoplasms; Coloring Agents; False Negative Reactions; Female; Humans; Intraoperative Period; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Compounds | 2003 |
Sentinel lymph node biopsy in breast cancer: results of intradermal periareolar tracer injection and follow-up of sentinel lymph node-negative patients.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Coloring Agents; Female; Humans; Injections, Intradermal; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium | 2004 |
Radioguided occult lesion localisation (ROLL) and sentinel node biopsy for impalpable invasive breast cancer.
Topics: Aged; Breast Neoplasms; Female; Humans; Iohexol; Lymphatic Metastasis; Middle Aged; Palpation; Radionuclide Imaging; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Stereotaxic Techniques; Technetium Tc 99m Aggregated Albumin; Ultrasonography, Interventional; Ultrasonography, Mammary | 2004 |
Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Female; Frozen Sections; Humans; Isotope Labeling; Middle Aged; Prospective Studies; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Treatment Outcome | 2005 |
Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; False Negative Reactions; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2006 |
Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control.
Topics: Axilla; Breast Neoplasms; Breast Neoplasms, Male; Coloring Agents; Female; Humans; Lymph Nodes; Male; Multicenter Studies as Topic; Quality Control; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin; Ultrasonography | 2000 |
Sentinel lymph node identification and sampling in women with early breast cancer using 99m Tc labelled dextran 500 and patent blue V dye.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Coloring Agents; Dextrans; Female; Humans; Lymph Nodes; Middle Aged; Organotechnetium Compounds; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes | 2001 |
82 other study(ies) available for sulfan blue and Breast Cancer
Article | Year |
---|---|
A case of immediate hypersensitivity reaction after an oral administration of patent blue dye.
Topics: Acetaminophen; Administration, Oral; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Breast Neoplasms; Coloring Agents; Excipients; Female; Humans; Hypersensitivity, Immediate; Intradermal Tests; Methacycline; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Tests; Urticaria | 2020 |
Kounis syndrome after patent blue dye injection for sentinel lymph node biopsy.
Topics: Anaphylaxis; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Coronary Angiography; Dual Anti-Platelet Therapy; Electrocardiography; Female; Humans; Injections, Subcutaneous; Kounis Syndrome; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2020 |
Anaphylactic shock perioperative to patent blue dye.
Topics: Anaphylaxis; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Coloring Agents; Diagnosis, Differential; Female; Humans; Lymph Nodes; Mastectomy; Middle Aged; Perioperative Period; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Tests; Treatment Outcome | 2018 |
Are pre-operative lymphoscintigrams needed for localization prior to sentinel node biopsy?: An audit to ensure safe practice and to provide another view.
Topics: Aged; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Lymphoscintigraphy; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid | 2018 |
Green blood plasma from a patient with breast cancer after sentinel lymph node biopsy.
Topics: Aged; Breast Neoplasms; Coloring Agents; Female; Humans; Plasma; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2018 |
Patent blue and air as an alternative for resection of nonpalpable breast lesions: a case series.
Topics: Adult; Air; Biopsy; Breast; Breast Neoplasms; Carcinoma; Early Detection of Cancer; Female; Humans; Hyperplasia; Mammography; Mastectomy, Segmental; Middle Aged; Operative Time; Reproducibility of Results; Retrospective Studies; Rosaniline Dyes; Treatment Outcome | 2014 |
Blue dye is sufficient for sentinel lymph node biopsy in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Tumor Burden; Young Adult | 2014 |
A prospective validation study of sentinel lymph node biopsy in multicentric breast cancer: SMMaC trial.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; False Negative Reactions; Feasibility Studies; Female; Humans; Lymph Node Excision; Lymph Nodes; Mastectomy; Middle Aged; Neoplasms, Multiple Primary; Organotechnetium Compounds; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2014 |
Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Female; Follow-Up Studies; Humans; Indocyanine Green; Lymph Nodes; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2014 |
Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; Female; Fluorescence; Follow-Up Studies; Humans; Image-Guided Biopsy; Immunoenzyme Techniques; Indocyanine Green; Lymph Nodes; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2016 |
Green plasma.
Topics: Breast Neoplasms; Coloring Agents; Female; Humans; Middle Aged; Plasma; Rosaniline Dyes | 2015 |
Magnetic sentinel node and occult lesion localization in breast cancer (MagSNOLL Trial).
Topics: Adult; Aged; Breast Neoplasms; Coloring Agents; Contrast Media; Female; Humans; Image-Guided Biopsy; Injections, Intralesional; Iron Compounds; Lymph Nodes; Lymphatic Metastasis; Magnetic Phenomena; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2015 |
A Case of Anaphylaxis to Patent Blue in a Patient with Sentinel Lymph Node Excision.
Topics: Anaphylaxis; Breast Neoplasms; Coloring Agents; Female; Humans; Intraoperative Complications; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Tests | 2016 |
[Sentinel lymph node biopsy in the breast carcinoma in clinical practice].
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Coloring Agents; False Negative Reactions; Female; Humans; Lymph Node Excision; Lymph Nodes; Middle Aged; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2008 |
[Exclusive use of blue dye to detect sentinel lymph nodes in breast cancer].
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Coloring Agents; False Negative Reactions; Feasibility Studies; Female; Follow-Up Studies; Humans; Lymph Nodes; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Young Adult | 2008 |
Effectiveness of immediate preoperative injection of radiopharmaceutical and blue dye for sentinel node biopsy in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Clinical Competence; Coloring Agents; Female; Humans; Lymph Node Excision; Middle Aged; Preoperative Care; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2009 |
DNA damaging effects of the dyes used in sentinel node biopsy: possible implications for clinical practice.
Topics: Breast Neoplasms; Cell Line, Transformed; Cell Line, Tumor; Coloring Agents; DNA Damage; Epithelial Cells; Humans; In Vitro Techniques; Indigo Carmine; Methylene Blue; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2009 |
Dye-containing histiocytes in frozen section of sentinel lymph node: a potential mimicker of carcinoma.
Topics: Artifacts; Breast Neoplasms; Coloring Agents; Diagnosis, Differential; False Positive Reactions; Female; Frozen Sections; Histiocytes; Humans; Lymphatic Metastasis; Paraffin Embedding; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2009 |
Sentinel node imaging in breast cancer using superficial injections: technical details and observations.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Coloring Agents; Female; Humans; Injections; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin; United Kingdom | 2009 |
Anaphylaxis to patent blue V: a case series and proposed diagnostic protocol.
Topics: Adult; Aged; Anaphylaxis; Breast Neoplasms; Coloring Agents; Drug Hypersensitivity; Female; Humans; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Tests | 2010 |
Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience.
Topics: Breast Neoplasms; Coloring Agents; Drug Hypersensitivity; Female; Humans; Lymphatic Metastasis; Randomized Controlled Trials as Topic; Rosaniline Dyes; Sentinel Lymph Node Biopsy; United Kingdom | 2010 |
[Patent blue V : inert dye or potent allergen].
Topics: Allergens; Anaphylaxis; Anesthesia; Breast Neoplasms; Coloring Agents; Drug Hypersensitivity; Female; Humans; Lymph Node Excision; Middle Aged; Monitoring, Intraoperative; Postoperative Care; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2010 |
Investigation of anaphylactic reaction after patent blue V dye injection.
Topics: Anaphylaxis; Breast Neoplasms; Coloring Agents; Female; Humans; Melanoma; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Tests | 2010 |
Observational study of blue dye-assisted four-node sampling for axillary staging in early breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Coloring Agents; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2010 |
[A woman with a blue coloured skin].
Topics: Aged; Breast Neoplasms; Carcinoma; Coloring Agents; Female; Humans; Hypersensitivity, Immediate; Rosaniline Dyes | 2010 |
Isotope-guided surgery for nonpalpable breast cancer.
Topics: Axilla; Breast Neoplasms; Calcinosis; China; Coloring Agents; Female; Humans; Immunohistochemistry; Mastectomy, Segmental; Middle Aged; Neoplasm Invasiveness; Palpation; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid | 2011 |
Sentinel lymph node biopsy in primary breast cancer: trust the radiolabeled colloid method and avoid unnecessary procedures.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid; Unnecessary Procedures | 2011 |
Processing sentinel nodes in breast cancer: when and how many?
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Breast Neoplasms, Male; Coloring Agents; Cost-Benefit Analysis; False Negative Reactions; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Palpation; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2011 |
[Dangerous blue?].
Topics: Anaphylaxis; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Lymph Nodes; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Shock | 2011 |
[Hypotension and oxygen saturation fall in a woman during sentinel lymph node biopsy].
Topics: Adult; Anaphylaxis; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Hypotension; Lymph Nodes; Lymphatic Metastasis; Oxygen; Radionuclide Imaging; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Shock | 2011 |
Anaphylaxis and patent Blue V.
Topics: Anaphylaxis; Breast Neoplasms; Coloring Agents; Drug Hypersensitivity; Female; Humans; Ovarian Neoplasms; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2011 |
Anaphylaxis to patent blue dye--the benefit and the risk.
Topics: Anaphylaxis; Breast Neoplasms; Coloring Agents; Drug Hypersensitivity; Female; Humans; Melanoma; Ovarian Neoplasms; Risk Assessment; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Tests | 2011 |
Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer.
Topics: Adult; Aged; Breast Neoplasms; Cell Tracking; Coloring Agents; Female; Ferric Compounds; Follow-Up Studies; Humans; Lymph Nodes; Magnetite Nanoparticles; Magnetometry; Middle Aged; Neoplasm Staging; Prognosis; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2013 |
Injecting patent blue dye V for sentinel lymph node biopsy without skin staining.
Topics: Breast Neoplasms; Coloring Agents; Female; Humans; Injections, Intradermal; Plastics; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Pigmentation | 2012 |
[Lymphatic mapping in axilla as possible prevention of lymphedema in breast cancer patients - first results of the anatomical study].
Topics: Aged; Arm; Axilla; Breast; Breast Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Vessels; Lymphedema; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2012 |
A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Coloring Agents; Female; Fluorescence; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Indocyanine Green; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2012 |
Adverse reaction; patent blue turning patient blue.
Topics: Aged; Anaphylaxis; Breast Neoplasms; Carcinoma, Ductal, Breast; Color; Coloring Agents; Female; Humans; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin; Urticaria | 2012 |
Hypersensitivity reactions to Patent Blue V in breast cancer surgery: a prospective multicentre study.
Topics: Aged; Anesthesia, General; Breast Neoplasms; Coloring Agents; Drug Hypersensitivity; Female; France; Histamine; Humans; Intraoperative Complications; Middle Aged; Prospective Studies; Risk Factors; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Tests; Treatment Outcome; Tryptases | 2013 |
[The sentinal node: the Dijon experience].
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Coloring Agents; False Negative Reactions; Feasibility Studies; Female; France; Gamma Cameras; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Patient Selection; Predictive Value of Tests; Prognosis; Rhenium; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium | 2002 |
Pulse oximetry and patent blue vital dye.
Topics: Breast Neoplasms; Coloring Agents; Female; Humans; Injections, Intradermal; Oximetry; Oxygen; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2003 |
Effect of increasing the surface sampled by imprint cytology on the intraoperative assessment of axillary sentinel lymph nodes in breast cancer patients.
Topics: Axilla; Breast Neoplasms; Humans; Immunohistochemistry; Intraoperative Period; Lymph Nodes; Neoplasm Staging; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2003 |
Anaphylaxis due to patent blue dye during lymphography, with negative skin prick test.
Topics: Anaphylaxis; Breast Neoplasms; Coloring Agents; Female; Humans; Intraoperative Period; Lymphography; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Tests | 2003 |
[False decrease in pulse oximetry readings due to patent blue in a patient with breast cancer].
Topics: Anesthesia, General; Blood Gas Analysis; Breast Neoplasms; False Positive Reactions; Female; Humans; Middle Aged; Monitoring, Intraoperative; Oximetry; Oxygen; Partial Pressure; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2003 |
Sentinel node biopsy for breast cancer: using local results for estimation of risk to the patient.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; False Negative Reactions; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Risk Factors; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2003 |
[Sentinel node biopsy in breast cancer and primary tumor dimension].
Topics: Adult; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Gamma Rays; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid | 2003 |
[Problems of detection and biopsy examination of sentinel lymph nodes in malignant melanomas and in breast carcinoma].
Topics: Breast Neoplasms; Coloring Agents; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2004 |
Clinical relevance of multiple sentinel nodes in patients with breast cancer.
Topics: Adult; Aged; Analysis of Variance; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2005 |
Prolonged skin staining after intradermal use of patent blue in sentinel lymph node biopsy for breast cancer.
Topics: Breast Neoplasms; Female; Follow-Up Studies; Humans; Injections, Intradermal; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin; Staining and Labeling; Time Factors | 2005 |
[False low oximetry reading caused by patent blue vital dye during breast surgery].
Topics: Adult; Breast Neoplasms; False Negative Reactions; Female; Humans; Oximetry; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2005 |
Axillary sentinel lymph nodes in breast cancer: a single lymphatic pathway drains the entire mammary gland.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Humans; Injections; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2005 |
[Sentinel lymphatic node biopsy for breast cancer in practice].
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Carcinoma; Coloring Agents; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2005 |
Anaphylactic reaction to patent blue V after sentinel lymph node biopsy.
Topics: Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Breast Neoplasms; Coloring Agents; Enzyme Inhibitors; Ephedrine; Female; Histamine; Humans; Hydrocortisone; Methylene Blue; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Tests; Tachycardia; Urticaria; Vasoconstrictor Agents | 2006 |
Patients blue on patent blue: an adverse reaction during four sentinel node procedures.
Topics: Aged; Anaphylaxis; Breast Neoplasms; Coloring Agents; Female; Humans; Middle Aged; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Urticaria | 2005 |
Optimal number of sentinel nodes after intradermal injection isotope and blue dye.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Injections, Intradermal; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid | 2006 |
The "Sentinel Chain": a new concept for prediction of axillary node status in breast cancer patients.
Topics: Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Predictive Value of Tests; Radionuclide Imaging; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium | 2006 |
[Functional anatomy of the lymphatic drainage of the breast: contribution of sentinel lymph node biopsy].
Topics: Axilla; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Female; Humans; Lymph; Lymph Nodes; Lymphatic Vessels; Mastectomy, Radical; Nipples; Pectoralis Muscles; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2006 |
Allergic reactions to patent blue dye.
Topics: Anaphylaxis; Breast Neoplasms; Coloring Agents; Female; Humans; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Urticaria | 2006 |
Allergy to technetium-labelled nanocolloidal albumin for sentinel node identification.
Topics: Aged, 80 and over; Breast Neoplasms; Coloring Agents; Drug Hypersensitivity; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2007 |
Combination blue dye sentinel lymph node biopsy and axillary node sampling: the Edinburgh experience.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; False Negative Reactions; Female; Humans; Lymph Nodes; Middle Aged; Retrospective Studies; Rosaniline Dyes; Scotland; Sentinel Lymph Node Biopsy | 2008 |
Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.
Topics: Adult; Aged; Aged, 80 and over; Arm; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Injections; Lymph Node Excision; Lymphatic Metastasis; Lymphedema; Middle Aged; Neoplasm Staging; Pilot Projects; Rosaniline Dyes | 2007 |
Initial experience in a cancer hospital in Nepal with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Cancer Care Facilities; Carcinoma, Ductal, Breast; Female; Humans; Middle Aged; Nepal; Palpation; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2007 |
Ex vivo search for sentinel node in postmastectomy specimens: should we use a transverse incision for mastectomy?
Topics: Breast Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Radical; Neoplasm Recurrence, Local; Prospective Studies; Radionuclide Imaging; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid | 2007 |
[Positive sentinel node biopsy in breast cancer: is axillary surgery necessary in all cases?].
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2007 |
Axillary reverse mapping in breast cancer: can we spare what we find?
Topics: Axilla; Breast Neoplasms; Female; Humans; Pilot Projects; Prognosis; Radionuclide Imaging; Rosaniline Dyes | 2008 |
Severe anaphylactic shock to Patent Blue V with cardiac arrest during breast carcinoma surgery with lymphatic mapping.
Topics: Anaphylaxis; Breast Neoplasms; Coloring Agents; Female; Humans; Injections, Subcutaneous; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2008 |
Atypical anaphylactic reaction to Patent Blue during sentinel lymph node biopsy for breast cancer.
Topics: Adult; Anaphylaxis; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Female; Humans; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2008 |
[The lymphotropic marking and biopsy of sentinel lymph nodes in T1 tumors--a new approach to the staging of axillary lymphatic metastasis in breast cancer].
Topics: Anthraquinones; Antineoplastic Agents; Axilla; Biopsy; Breast Neoplasms; Carcinoma; Coloring Agents; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Mitoxantrone; Neoplasm Staging; Rosaniline Dyes; Staining and Labeling; Vinyl Compounds | 1997 |
[Identification of axillary sentinel node by lymphotropic dye in breast cancer. Feasibility study apropos of 128 cases].
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biopsy; Breast Neoplasms; Feasibility Studies; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Staging; Rosaniline Dyes; Sensitivity and Specificity | 1998 |
[Demonstration of the sentinel lymph node in axillary dissection for breast cancer].
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; False Negative Reactions; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoplasm Invasiveness; Predictive Value of Tests; Rosaniline Dyes; Sensitivity and Specificity | 1998 |
[Identification of sentinel lymph node in breast cancer: experience from the Institut Curie].
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Rosaniline Dyes | 1999 |
The role of sentinel lymph node biopsy in breast cancer.
Topics: Biopsy; Breast; Breast Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Rosaniline Dyes; Sensitivity and Specificity; Technetium Tc 99m Sulfur Colloid | 1999 |
[Anaphylactic shock due to "patent blue" used to search for the sentinel node].
Topics: Anaphylaxis; Breast Neoplasms; Coloring Agents; Female; Humans; Lymph Node Excision; Lymphography; Mastectomy, Segmental; Middle Aged; Rosaniline Dyes | 1999 |
Clinical and histological factors associated with sentinel node identification in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Axilla; Biopsy; Breast Neoplasms; Coloring Agents; Female; Forecasting; Humans; Intraoperative Care; Logistic Models; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Palpation; Preoperative Care; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Technetium Tc 99m Sulfur Colloid; Treatment Outcome | 2000 |
[Interest of periareolar injection for colorimetric detection of sentinel node in breast cancer].
Topics: Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Injections; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Nipples; Rosaniline Dyes; Sensitivity and Specificity | 2000 |
Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Topics: Adult; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Coloring Agents; Female; Humans; Intraoperative Care; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Particle Size; Preoperative Care; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2000 |
[Locating the sentinel node in breast cancer by gamma probe and staining agent. Preliminary study].
Topics: Adult; Aged; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Modified Radical; Middle Aged; Neoplasm Staging; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid | 2000 |
[Lymph node mapping and axillary sentinel lymph node biopsy in 243 invasive breast cancers with no palpable nodes. The south Lyon hospital center experience].
Topics: Biopsy; Breast Neoplasms; Coloring Agents; Evans Blue; False Negative Reactions; Female; France; Humans; Immunohistochemistry; Intraoperative Care; Mastectomy; Neoplasm Staging; Prospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2000 |
Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer.
Topics: Aged; Anaphylaxis; Breast Neoplasms; Coloring Agents; Female; Humans; Methylhistamines; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Serine Endopeptidases; Tryptases | 2001 |
Sentinel lymph node detection for breast cancer: which patients are best suited for the patent blue dye only method of identification?
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Clinical Competence; Coloring Agents; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Quality Control; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2001 |
Perioperative locoregional application of mitoxantrone in patients with early breast carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Coloring Agents; Female; Follow-Up Studies; Humans; Lymph Nodes; Lymphadenitis; Middle Aged; Mitoxantrone; Neoplasm Staging; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2001 |
[Anaphylactic shock after injection of patent blue for sentinel lymph node biopsy].
Topics: Anaphylaxis; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Melanoma; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2002 |
Anaphylaxis after peritumoral injection of sulphan blue 1% for identification of the sentinel node in lymphatic mapping of the breast.
Topics: Anaphylaxis; Breast Neoplasms; Carcinoma, Ductal, Breast; Coloring Agents; Female; Humans; Intradermal Tests; Middle Aged; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2001 |